Despite its success, clinical and logistical roadblocks to mRNA cancer vaccine development remain.
Martin Lachs
Advertisement
Martin Lachs, PhD, is VP, Project Management Oncology at ICON.
Articles by Martin Lachs
Advertisement
Latest Updated Articles
Logistical Considerations in mRNA Vaccine DevelopmentPublished: September 15th 2023 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
5
